找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: mTOR Inhibition for Cancer Therapy: Past, Present and Future; Monica Mita,Alain Mita,Eric K. Rowinsky Book 2016 Springer-Verlag France 201

[复制链接]
查看: 45842|回复: 35
发表于 2025-3-21 19:18:56 | 显示全部楼层 |阅读模式
书目名称mTOR Inhibition for Cancer Therapy: Past, Present and Future
编辑Monica Mita,Alain Mita,Eric K. Rowinsky
视频video
概述First book on that topic.Input and perspectives by international leaders?.Preclinical and clinical data available on the subject have been integrated.A dedicated chapter on toxicity profile of mTOR in
图书封面Titlebook: mTOR Inhibition for Cancer Therapy: Past, Present and Future;  Monica Mita,Alain Mita,Eric K. Rowinsky Book 2016 Springer-Verlag France 201
描述.This book describes the challenges involved in developing mTOR inhibitors for cancer treatment, starting with an in-depth examination of their molecular mechanism of action, with emphasis on the class side-effects, efficacy and mechanisms of resistance, as well as on promising novel directions for their development, including novel compounds and rational combinations with other anti-neoplastic drugs.  .Over the last 10 years, inhibitors of mTOR have emerged as a major class of anticancer drugs. Two rapamycin analogs are currently approved for the treatment of renal cell carcinoma, and it is estimated that a variety of other tumor types could benefit from mTOR inhibition, with numerous clinical trials (including pivotal registration trials) already underway. Second-generation small-molecule inhibitors of the pathway have also shown promise in terms of their superior tolerability and efficacy and are undergoing extensive clinical evaluation, with an estimated 30+ compoundscurrently under evaluation. .
出版日期Book 2016
关键词Akt; cancer; mTOR; rapamycin; Molecular
版次1
doihttps://doi.org/10.1007/978-2-8178-0492-7
isbn_softcover978-2-8178-0557-3
isbn_ebook978-2-8178-0492-7
copyrightSpringer-Verlag France 2016
The information of publication is updating

书目名称mTOR Inhibition for Cancer Therapy: Past, Present and Future影响因子(影响力)




书目名称mTOR Inhibition for Cancer Therapy: Past, Present and Future影响因子(影响力)学科排名




书目名称mTOR Inhibition for Cancer Therapy: Past, Present and Future网络公开度




书目名称mTOR Inhibition for Cancer Therapy: Past, Present and Future网络公开度学科排名




书目名称mTOR Inhibition for Cancer Therapy: Past, Present and Future被引频次




书目名称mTOR Inhibition for Cancer Therapy: Past, Present and Future被引频次学科排名




书目名称mTOR Inhibition for Cancer Therapy: Past, Present and Future年度引用




书目名称mTOR Inhibition for Cancer Therapy: Past, Present and Future年度引用学科排名




书目名称mTOR Inhibition for Cancer Therapy: Past, Present and Future读者反馈




书目名称mTOR Inhibition for Cancer Therapy: Past, Present and Future读者反馈学科排名




单选投票, 共有 0 人参与投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 20:49:01 | 显示全部楼层
发表于 2025-3-22 01:30:30 | 显示全部楼层
发表于 2025-3-22 08:32:38 | 显示全部楼层
https://doi.org/10.1007/978-2-8178-0492-7Akt; cancer; mTOR; rapamycin; Molecular
发表于 2025-3-22 10:50:11 | 显示全部楼层
发表于 2025-3-22 13:50:35 | 显示全部楼层
Monica Mita,Alain Mita,Eric K. RowinskyFirst book on that topic.Input and perspectives by international leaders?.Preclinical and clinical data available on the subject have been integrated.A dedicated chapter on toxicity profile of mTOR in
发表于 2025-3-22 19:37:43 | 显示全部楼层
发表于 2025-3-23 01:05:21 | 显示全部楼层
mTOR Inhibition for Cancer Therapy: Past, Present and Future978-2-8178-0492-7
发表于 2025-3-23 01:51:49 | 显示全部楼层
Book 2016 already underway. Second-generation small-molecule inhibitors of the pathway have also shown promise in terms of their superior tolerability and efficacy and are undergoing extensive clinical evaluation, with an estimated 30+ compoundscurrently under evaluation. .
发表于 2025-3-23 06:28:40 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-3 03:18
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表